Strategies for Effective Pain Management in Clinical Practice (Module 1)
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/home.html for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Learning Objectives
Discuss all options for pain management, including non-pharmacologic and pharmacologic approaches.
Explain the definitions and mechanisms of pain
Identify the appropriate pain assessment and assessment of potential risk factors for abuse and opioid use disorder/addiction.
Additional Information
Charles E. Argoff, MD, FABPM:
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Albany, NY
Oscar A. de Leon-Casasola, MD:
Professor of Anesthesiology and Medicine
Senior Vice-Chair
The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
Chief, Pain Medicine and Professor of Oncology
Roswell Park Cancer Institute
Buffalo, NY
Katherine E. Galluzzi, DO, CMD, FACOFP:
Professor and Chair
Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Philadelphia, PA
Disclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Charles E. Argoff, MD, FABPM: Advisory Board for Amgen, BioDelivery Sciences International, Inc., Clexio Biosciences, Nevro, Neumentum, Regeneron Pharmaceuticals, SK Life Sciences, Teva Pharmaceuticals, and Tremeau Pharmaceuticals, Inc., and Vertex. Consulting for EnZen Therapeutics, Opioid PMR Consortium, and XGene Pharma. Contracted Research for AbbVie, Allergan, Amgen, Lilly, Lundbeck, and Teva. Services Provided for Promotional Purposes for Collegium. Speaker’s Bureau for AbbVie, Amgen, Biohaven, Lilly, Nevro, Redhill Pharma, and Teva.
Oscar A. de Leon-Casasola, MD: Advisory Board for Esteve Pharma, Heron Therapeutics, Medtronic, Tremeau Pharma.
Katherine E. Galluzzi, DO, CMD, FACOFP: No relevant financial relationships to disclose.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
AMA PRA Category 1 Credits™
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.
Designation Statement
This activity is approved for 1.28 contact hours of continuing education, which includes 0.334 hours of pharmacology.
MOC Credit Information
Successful completion of this CME activity (“Strategies for Effective Pain Management in Clinical Practice”), which includes participation in the evaluation component, enables the participant to earn up to 3.5 Medical Knowledge & Patient Safety MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory (https://www.continuingcertification.org), Strategies for Effective Pain Management in Clinical Practice has met the requirements as a MOC Part II Self-Assessment Activity and MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
MOC Part II Self-Assessment Activity:
Physical Medicine and Rehabilitation
ABMS MOC Part II CME Activity:
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
State Licensure Requirements
This activity satisfies topic-specific CME/CE requirements (pain management, controlled substances, etc.) of many state licensing boards. Please check with your state’s licensing boards for specific requirements, and print this page as appropriate for documentation.
This activity is approved for Pain Management and Prescription of Opioids requirements from the Texas Medical Board/Board of Nursing, which may also satisfy the medical ethics and/or professional responsibility.
Instructions for Obtaining Credit
Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of the 3 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.
Available Credit
- 1.28 AANP Contact Hours
- 0.33 AANP Pharmacology Contact Hours
- 1.25 ABMS MOC
- 1.25 AMA PRA Category 1 Credit™
This course is offered through Pri-Med.
To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!